Toll Free: 800-370-5452
International: +1-617-969-5452

Search form

Blog

  • The production of new biopharmaceuticals continues to expand at a rapid pace, and these cutting-edge products continue to command an ever larger share of the annual pharmaceuticals market. Because the market has grown so quickly, it makes sense to review some of the specifics regarding the biopharmaceutical manufacturing process. For example, what is the difference between traditional pharmaceuticals and...
  • The biopharmaceuticals market continues to heat up. In short, every aspect of this fast-growing industry is trending upward. Product pipelines are increasingly full, companies are adding staff and R&D expenditures are increasing — and that means process lines and production facilities are expanding. Sales revenues and profits are rapidly rising. According to industry insiders, growth has exceeded 12% annually,...
  • Agglomeration is a process by which individual particles of a given substance clump together, forming a more or less solid mass. Such a mass also is known as an agglomeration. The process of agglomeration may be useful in some instances — such as consumer cereals featuring clusters — but in most manufacturing scenarios, agglomeration is undesirable. In these cases, the uniform dispersion of individual particles...
  • Homogenization is a process that’s nearly as old as human civilization. Consider humble bread. It’s hard to imagine societies advancing without the invention of bread, made possible by grinding grain into powdered meal. This example of crude grinding underscores the benefits of homogenization. Nutrients are unlocked from tough seeds, facilitating the chemical transformation of fermentation which follows...
  • The concept of liposomal delivery of drug payloads is not new. For decades, pharmaceutical manufacturers have harnessed this ingenious approach to encapsulating active pharmaceutical ingredients in a vesicle comprised of phospholipid bilayers to improve bioavailability. Bioavailability is a key stumbling block when it comes to drug design and delivery. Certain potentially beneficial substances suffer from extremely...
  • Pharmaceutical nanotechnology is the exciting, rapidly emerging branch of medical science that deals with harnessing nanoscale materials as drug delivery and/or diagnostic tools. As drug delivery tools, nano-delivery systems can be used to enhance the site-specific, targeted delivery of precise medicines. This typically results in significant reductions in side effects and concomitant improvements in efficacy....
  • Although Microfluidizer® high shear fluid processors are technically high-pressure homogenizers, they share little in common with conventional homogenizers. Industries ranging from pharmaceuticals and biotechnology to cosmetics, nutraceuticals and food processing employ homogenizers during critical phases of processing and/or production. Many companies within these industries have discovered they can streamline...
  • Inhalation therapy has been used to deliver various pharmaceutical preparations directly to the lungs for more than a century. Primarily targeting lung-related conditions such as asthma, cystic fibrosis or chronic obstructive pulmonary disease (COPD), these aerosol-based treatments delivered medications deep into the lungs and alveoli, providing rapid onset of action. More recently, inhalation therapy has been...
  • Milk homogenization has been practiced for more than a century. Milk comes from the source as a more or less natural emulsion. The milk protein, casein, forms an emulsifying membrane that stabilizes milk fat in its aqueous matrix. But milk fat, in the form of cream, quickly rises to the top once this nutritious beverage leaves the cow. Homogenization serves to prevent fat globules from separating and rising to the...
  • For years, the writing has been on the wall: The golden age of blockbuster drugs was fun while it lasted, but it is ultimately unsustainable. For starters, these drugs tend to provide therapeutic benefits to only a select proportion of the patients who take them. Indeed, within more than a dozen therapeutic categories, patient response rates to the great majority of “standard” drug therapies do not reach 60 percent...
Proven Results

Let us demonstrate how a Microfluidizer® can achieve your nanomaterial processing and product quality goals.

Lab Testing Services